W. Bleyer

发表

A Reflection on the Work of Gianni Bonadonna from the Viewpoint of the Global Challenge of Adolescents and Young Adults with Cancer

A. Bleyer, R. Barr, W. Bleyer, 2017, Tumori.

The U.S. pediatric cancer clinical trials programmes: international implications and the way forward.

W. Bleyer, 1997, European journal of cancer.

National Cancer Clinical Trials: Access; Adolescents Do Not Children Have Equal

B. Pollock, L. Robison, O. Brawley, 1997 .

Cancer chemotherapy in infants and children.

W. Bleyer, 1985, Pediatric clinics of North America.

New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting.

W. Hall, J. Hoffman, R. Martuza, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future.

A. Bleyer, L. Ries, A. Ferrari, 2016, JAMA pediatrics.

Workgroup #1: Long‐term care and lifetime follow‐up

A. M. Brady, J. Krischer, C. Coltman, 1993, Cancer.

Acute lymphoblastic leukemia in children.Advances and prospectus

W. Bleyer, W. Archie Bleyer, 1990, Cancer.

Septicemia in Childhood Malignancy

J. Miser, A. Miser, W. Bleyer, 1981, Clinical pediatrics.

New vistas for leucovorin in cancer chemotherapy.

W. Bleyer, 1989, Cancer.

The impact of childhood cancer on the United States and the world

W. Bleyer, 1990, CA: a cancer journal for clinicians.

Obesity and outcome in pediatric acute lymphoblastic leukemia.

A. Bleyer, H. Sather, B. Lange, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potential favorable impact of the affordable care act of 2010 on cancer in young adults in the United States.

W. Bleyer, W. Archie Bleyer, 2010, Cancer journal.

Neuroblastoma screening in the united states

L. Foxhall, J. Ater, B. Therrell, 1998, Cancer.

Re: recruiting minorities into clinical trials: toward a participant-friendly system.

W. Bleyer, 1996, Journal of the National Cancer Institute.

A system for classifying cancers diagnosed in adolescents and young adults

E. Steliarova-Foucher, L. Ries, G. Gatta, 2020, Cancer.

National cancer clinical trials: children have equal access; adolescents do not.

A. Bleyer, B. Pollock, L. Robison, 1997, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer Group.

I. Bernstein, W. Woods, C. Willman, 1995, Leukemia.

Incidence of childhood and adolescent cancer in Texas.

N. Weiss, L. Frankel, W. Bleyer, 1996, Texas medicine.

Epidemiologic impact of children with brain tumors

A. Bleyer, W. Bleyer, 1999, Child's Nervous System.

What can be learned about childhood cancer from “cancer statistics review 1973–1988”

W. Bleyer, 1993, Cancer.

Leptomeningeal cancer in leukemia and solid tumors.

W. Bleyer, T. Byrne, W. Archie Bleyer, 1988, Current problems in cancer.

Conduct of phase I trials in children with cancer.

G. Vassal, M. Bernstein, G. Reaman, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Importance of dose intensity in neuro-oncology clinical trials: summary report of the Sixth Annual Meeting of the Blood-Brain Barrier Disruption Consortium.

W. Hall, T. Cloughesy, J. Cairncross, 2001, Neuro-oncology.

Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.

E. Kosnik, W. Bleyer, J. Geyer, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypocalcemia, hyperphosphatemia, and dehydration following a single hypertonic phosphate enema.

W. Bleyer, R. F. Davis, G. Okamoto, 1977, The Journal of pediatrics.

Improvement of oncology education at the University of Washington School of Medicine, 1984‐1988

M. Trevisan, J. Carline, W. Bleyer, 1990, Academic medicine : journal of the Association of American Medical Colleges.

Central nervous system leukemia.

W. Bleyer, W. Bleyer, 1988, Pediatric clinics of North America.

Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.

H. Sather, G. Reaman, P. Steinherz, 1988, The American journal of pediatric hematology/oncology.

Pharmacokinetics of Commonly used Anti-Leukemic agents in Children

F. Balis, W. Bleyer, D. Poplack, 1991 .

Long-term remission from acute myelogenous leukemia after bone marrow transplantation and recovery from acute graft-versus-host reaction and prolonged immunoincompetence.

R. Blaese, W. Bleyer, R. Graw, 1975, Blood.

Bone-marrow transplantation following combination chemotherapy immunosuppression (B.A.C.T.) in patients with acute leukemia.

J. Bull, H. Gralnick, E. Henderson, 1974, Transplantation proceedings.

Oral Cancer Chemotherapy in Paediatric Patients

W. Bleyer, M. Danielson, 2012, Drugs.

Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study.

L. Robison, H. Sather, R. Heyn, 1991, Medical and pediatric oncology.

Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.

H. Sather, G. Reaman, P. Steinherz, 1991, Medical and pediatric oncology.

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995

W. Bleyer, G. Hammond, N. Heerema, 2000, Leukemia.

Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL).

A. Bleyer, H. Sather, J. Lukens, 1984, International journal of radiation oncology, biology, physics.

Infant Cancer in the U.S.: Histology‐Specific Incidence and Trends, 1973 to 1992

L. Robison, J. Gurney, R. Severson, 1997, Journal of pediatric hematology/oncology.

Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.

H. Sather, J. Lukens, P. Coccia, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T‐cell phenotype or other poor prognostic features

H. Sather, F. Uckun, P. Steinherz, 1998, Cancer.

Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.

P. Steinherz, M. Trigg, W. Bleyer, 1996, International journal of radiation oncology, biology, physics.

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.

G. Reaman, P. Steinherz, P. Gaynon, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

H. Sather, J. Lukens, S. Siegel, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group.

S. Feig, H. Sather, M. Trigg, 1996, Medical and pediatric oncology.

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

H. Sather, P. Steinherz, M. Trigg, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hobson's choice in the CNS radioprophylaxis of small cell lung cancer.

W. Bleyer, 1988, International journal of radiation oncology, biology, physics.

Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure

Denis R. Miller, H. Sather, G. Reaman, 1991, Cancer.

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma

C. Anders, S. Hunger, L. Boardman, 2016, Cancer.

Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival, and importance of clinical trials.

W. Bleyer, 2002, Medical and pediatric oncology.

Strategies for the treatment of children with acute lymphoblastic leukemia and unfavorable presenting features.

H. Sather, G. Reaman, P. Steinherz, 1987, Haematology and blood transfusion.

Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.

H. Sather, B. Amendola, G. Reaman, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.

H. Sather, G. Reaman, P. Steinherz, 1987, Cancer treatment reports.

Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P

P. Nathan, S. Steinberg, A. Bleyer, 2006, Leukemia & lymphoma.

Open-wedge testicular biopsy in childhood acute lymphoblastic leukemia after two years of maintenance therapy: diagnostic accuracy and influence on outcome--a report from Children's Cancer Study Group.

H. Sather, J. Lukens, P. Coccia, 1990, Blood.

Use of minors as bone marrow donors: current attitude and management. A survey of 56 pediatric transplantation centers.

R. Champlin, R. Pentz, W. Bleyer, 1996, The Journal of pediatrics.

Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.

H. Sather, G. Reaman, P. Steinherz, 1990, Medical and pediatric oncology.

INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES Early Conclusions of Study CCG-106 by the Childrens Cancer Study Group

H. Sather, P. Steinherz, P. Gaynon, 1988, The Lancet.

Birth weight, ethnicity, and occurrence of cancer in children: a population-based, incident case–control study in the State of Texas, USA

N. Weiss, S. Carozza, S. Cooper, 2002, Cancer Causes & Control.

Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults

L. Ries, A. Geiger, D. Dahlke, 2016, Cancer.

The management of cancer in the older adolescent.

W. Bleyer, K. Albritton, 2003, European journal of cancer.

Title Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults Permalink

L. Ries, B. Pollock, A. Geiger, 2016 .

YIELD OF UNPREDICTED BONE-MARROW RELAPSE DIAGNOSED BY ROUTINE MARROW ASPIRATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA A Report from the Children's Cancer Study Group

H. Sather, D. Hammond, P. Coccia, 1984, The Lancet.

Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.

D. Hammond, W. Krivit, W. Bleyer, 1979, Cancer treatment reports.

Biology and pathogenesis of CNS leukemia.

W. Bleyer, W. Archie Bleyer, 1989, The American journal of pediatric hematology/oncology.

Infants with medulloblastoma: a single institution review of survival.

W. Bleyer, B. Griffin, M. Levy, 1991, Neurosurgery.

Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future

D. R. Lewis, A. Geiger, Ashley Wilder Smith, 2016, Cancer.

Bone marrow transplantation for leukemia.

A. Deisseroth, R. Champlin, W. Bleyer, 1993, The Journal of pediatrics.

Phase I Evaluation of Oral and Intravenous Vinorelbine in Pediatric Cancer Patients: A Report from the Children's Oncology Group

T. Madden, M. Ames, J. Kuttesch, 2006, Clinical Cancer Research.

Future development of amifostine in cancer treatment.

D. Alberts, W. Bleyer, 1996, Seminars in oncology.

Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.

D. Hammond, W. Krivit, W. Bleyer, 1979, Cancer treatment reports.

Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

J. Lukens, S. Siegel, D. Hammond, 1985, Cancer treatment reports.

Eight drugs in one day chemotherapy in children with brain tumors: a critical toxicity appraisal.

W. Bleyer, J. Geyer, T. Pendergrass, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase IEvaluation of Oral and IntravenousVinorelbine in Pediatric Cancer Patients : AReport from the Children ’ s Oncology Group

J. Kuttesch, M. Krailo, W. Bleyer, 2006 .

A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.

M. Krailo, C. Fryer, W. Bleyer, 1987, Medical and pediatric oncology.

Homebound schooling is the least favorable option for continued education of adolescent cancer patients: a preliminary report.

W. Bleyer, Nancy S. Searle, Nancy S Searle, 2003, Medical and pediatric oncology.

An overview of adverse late effects of cancer chemotherapy in children

W. Bleyer, 1987 .

The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.

M. Krailo, C. Fryer, W. Bleyer, 1988, Journal of pediatric surgery.

Treatment of patients with metastatic osteogenic sarcoma: a report from the Children's Cancer Study Group.

J. Lukens, B. Lampkin, C. Fryer, 1984, Cancer treatment reports.

Prognosis and treatment after relapse of acute lymphoblastic leukemia and non‐Hodgkin's lymphoma: 1985: A report from the childrens cancer study group

H. Sather, W. Bleyer, G. Hammond, 1986, Cancer.

Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.

H. Sather, P. Coccia, W. Bleyer, 1987, Haematology and blood transfusion.

The staging of childhood acute lymphoblastic leukemia: strategies of the Childrens Cancer Study Group and a three-dimensional technic of multivariate analysis.

H. Sather, J. Lukens, S. Siegel, 1986, Medical and pediatric oncology.

Improved three-year disease-free survival in osteogenic sarcoma.

I. Bernstein, W. Bleyer, J. Haas, 1982, Journal of Bone and Joint Surgery-british Volume.

Favorable prognosis for brainstem gliomas in neurofibromatosis

M. Berger, W. Bleyer, J. Geyer, 1989, Journal of Neuro-Oncology.

Remaining problems in the staging and treatment of childhood lymphoblastic leukemia.

W. Bleyer, 1989, American Journal Of Pediatric Hematology/Oncology.

New horizons on the landscape of AYA oncology

W. Bleyer, R. Barr, W. Archie Bleyer, 2017, Pediatric blood & cancer.

Acute lymphoid leukemia.

W. Bleyer, 1983, Pediatric annals.

Seventy percent survival in childhood non-hodgkin’s lymphoma

I. Bernstein, J. Miser, A. Miser, 1980 .

Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia.

W. Bleyer, W. Bleyer, D. Poplack, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Leukoencephalopathy detectable by magnetic resonance imaging: much ado about nothing? Regarding Matsumoto et al. IJROBP 32:913-918; 1995.

W. Bleyer, 1995, International journal of radiation oncology, biology, physics.

The past and future of cancer in the young.

W. Bleyer, 1995, Pediatric dentistry.

New horizons on the landscape of AYA oncology

W. Bleyer, R. Barr, 2017, Pediatric blood & cancer.

Cranial irradiation is not necessary for central-nervous-system prophylaxis in pediatric non-Hodgkin's lymphoma.

W. Bleyer, S. Murphy, 1987, International Journal of Radiation Oncology, Biology, Physics.

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma

C. Anders, S. Hunger, L. Boardman, 2016, Cancer.

Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “nonmalignant/noninvasive” tumors

L. Ries, L. Harlan, T. Keegan, 2016, Cancer.